Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

NCT02289820 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02289820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults
Lead sponsor
MedImmune LLC
Phase
Phase 1
Overall status
Completed
Start date
January 5, 2015
Completion date
February 24, 2016
Enrollment
363 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv)